Product Code: SR112024A4370
The global clinical microbiology market size reached US$ 4.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.
Clinical microbiology is a field of medical science that assists in diagnosing, preventing, and treating various infectious diseases. It focuses on identifying the presence of bacterial, viral, fungal, or parasitic agents and determining the susceptibility of microorganisms by conducting various tests. Some of the commonly used testing methods are direct smears and stains, cultures, molecular analysis, serological testing, and antibiotic susceptibility testing. Presently, clinical microbiology is gaining traction across the globe on account of its effective antibiotic administration and improved treatment outcomes.
Clinical Microbiology Market Trends:
The increasing prevalence of infectious diseases around the world represents one of the primary factors propelling the growth of the market. Additionally, the rising air and water pollution levels are increasing incidences of respiratory diseases among individuals, which, in turn, is driving the market. Apart from this, the integration of automation in clinical microbiology is creating a favorable outlook for market growth as it enables specimen traceability, eliminates delays in incubations and improves the efficiency of laboratory operations. Furthermore, the leading players are focusing on introducing technological advancements in disease diagnostics, such as the adoption of machine learning (ML), which aids in providing quick and accurate results. This, along with the introduction of several molecular diagnostic techniques, is offering lucrative growth opportunities to the market. Moreover, the rising adoption of advanced clinical diagnostic techniques, including real-time polymerase chain reaction (PCR), next-generation sequencing (NGS), and mass spectrometry for effective identification and characterization of pathogens, is acting as another growth-inducing factor. Other major factors, including the increasing number of new microorganisms causing various infectious diseases and the burgeoning healthcare sector across the globe, are anticipated to impel the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global clinical microbiology market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.
Breakup by Product:
Laboratory Instruments
Incubators
Gram Stainers
Bacterial Colony Counters
Autoclave Sterilizers
Petri Dish Fillers
Automated Culture Systems
Microbiology Analyzers
Molecular Diagnostic Instruments
Microscopes
Mass Spectrometers
Reagents
Breakup by Application:
Respiratory Diseases
Bloodstream Infections
Gastrointestinal Diseases
Sexually Transmitted Diseases
Urinary Tract Infections (UTIs)
Periodontal Diseases
Others
Breakup by End User:
Hospitals and Diagnostic Centers
Custom Lab Service Providers
Academic and Research Institutes
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc, Bruker Corporation, Danaher Corporation, Hologic Inc., Merck KGaA, QIAGEN N.V and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
- 1. What was the size of the global clinical microbiology market in 2023?
- 2. What is the expected growth rate of the global clinical microbiology market during 2024-2032?
- 3. What has been the impact of COVID-19 on the global clinical microbiology market?
- 4. What are the key factors driving the global clinical microbiology market?
- 5. What is the breakup of the global clinical microbiology market based on the product?
- 6. What is the breakup of the global clinical microbiology market based on the application?
- 7. What is the breakup of the global clinical microbiology market based on the end user?
- 8. What are the key regions in the global clinical microbiology market?
- 9. Who are the key players/companies in the global clinical microbiology market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Clinical Microbiology Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Laboratory Instruments
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Incubators
- 6.1.2.2 Gram Stainers
- 6.1.2.3 Bacterial Colony Counters
- 6.1.2.4 Autoclave Sterilizers
- 6.1.2.5 Petri Dish Fillers
- 6.1.3 Market Forecast
- 6.2 Automated Culture Systems
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Microbiology Analyzers
- 6.2.2.2 Molecular Diagnostic Instruments
- 6.2.2.3 Microscopes
- 6.2.2.4 Mass Spectrometers
- 6.2.3 Market Forecast
- 6.3 Reagents
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Application
- 7.1 Respiratory Diseases
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Bloodstream Infections
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Gastrointestinal Diseases
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Sexually Transmitted Diseases
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Urinary Tract Infections (UTIs)
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Periodontal Diseases
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Others
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals and Diagnostic Centers
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Custom Lab Service Providers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Academic and Research Institutes
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 3M Company
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Abbott Laboratories
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Agilent Technologies Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Becton Dickinson and Company
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 bioMerieux SA
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Bio-Rad Laboratories Inc
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Bruker Corporation
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Danaher Corporation
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Hologic Inc.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Merck KGaA
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 QIAGEN N.V
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Thermo Fisher Scientific Inc.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis